The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Expression of interleukin 2 receptors on activated human B cells.
Open accessAbstract
Using anti-Tac, a monoclonal anti-interleukin 2 (IL-2) receptor antibody, we have explored the possibility that certain activated B cells display receptors for IL-2. Resting normal B cells and unselected B cell lines established from normal individuals were Tac antigen negative. In contrast, the cell surface Tac antigen expression was demonstrable on 6 of 10 B cell lines from patients with Burkitt's lymphoma, 5 of 6 B cell lines derived from patients with HTLV-I-associated adult T cell leukemia (including all four that had integrated HTLV-I into their genome), and on certain normal B cells activated with pokeweed mitogen. Furthermore, cloned Epstein-Barr virus-transformed B cell lines derived from Tac-positive normal B cells continued to express the Tac antigen in long-term cultures and manifested high affinity IL-2 receptors identified in binding studies with purified radiolabeled IL-2. The line 5B4 developed in the present study could be induced with purified JURKAT-derived or recombinant IL-2 to express a larger number of IL-2 receptors. Furthermore, the addition of IL-2 to the 5B4 B cell line augmented IgM synthesis, which could be blocked by the addition of anti-Tac. The size of the IL-2 receptors expressed on the cloned normal B cell lines was similar (53,000-57,000 daltons) to that of receptors on phytohemagglutinin-stimulated T cell lymphoblasts. Thus, certain malignant and activated normal B cells display the Tac antigen and manifest high affinity receptors for IL-2. These data suggest that IL-2 may play a role in the differentiation of activated B cells into immunoglobulin-synthesizing and -secreting cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS
Scatchard, G. (1949) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1949.tb27297.x · Cited by 19,778
Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-Sepharose
Ey, P. L., Prowse, S. J., & Jenkin, C. R. (1978) · Immunochemistry · doi:10.1016/0161-5890(78)90070-6 · Cited by 2,685
Uchiyama, T., Broder, S., & Waldmann, T. A. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.126.4.1393 · Cited by 1,329
Self-citationT cell growth factor receptors. Quantitation, specificity, and biological relevance
Robb, R., Munck, A., & Smith, K. (1981) · The Journal of Experimental Medicine · doi:10.1084/jem.154.5.1455 · Cited by 1,061
Self-citationLeonard, W. J., Depper, J. M., Uchiyama, T., Smith, K. A., Waldmann, T. A., & Greene, W. C. (1982) · Nature · doi:10.1038/300267a0 · Cited by 864
Self-citationROLE OF SUPPRESSOR T CELLS IN PATHOGENESIS OF COMMON VARIABLE HYPOGAMMAGLOBULINÆMIA
Waldmann, T. A., Broder, S., Blaese, R. M., Durm, M., Blackman, M. A., & Strober, W. (1974) · The Lancet · doi:10.1016/s0140-6736(74)91940-0 · Cited by 705
Self-citationThe Sézary syndrome: a malignant proliferation of helper T cells.
Broder, S., Edelson, R. L., Lutzner, M. A., Nelson, D. L., MacDermott, R. P., Durm, M. E., Goldman, C. K., Meade, B. D., & Waldmann, T. A. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108585 · Cited by 474
Self-citationT cell-derived B cell differentiation factor(s). Effect on the isotype switch of murine B cells.
Isakson, P. C., Puré, E., Vitetta, E. S., & Krammer, P. H. (1982) · The Journal of experimental medicine · doi:10.1084/jem.155.3.734 · Cited by 442
Regulation of B-Cell Growth and Differentiation by Soluble Factors
Howard, M., & Paul, W. E. (1983) · Annual Review of Immunology · doi:10.1146/annurev.iy.01.040183.001515 · Cited by 430
Ultra-Rapid Fluorescent Labelling of Proteins
Rinderknecht, H. (1962) · Nature · doi:10.1038/193167b0 · Cited by 352
Cited by
Noguchi, M. (1993) · Cell · doi:10.1016/0092-8674(93)90167-o · Cited by 1,320
Cloning of the γ Chain of the Human IL-2 Receptor
Takeshita, T., Asao, H., Ohtani, K., Ishii, N., Kumaki, S., Tanaka, N., Munakata, H., Nakamura, M., & Sugamura, K. (1992) · Science · doi:10.1126/science.1631559 · Cited by 840
Peptide growth factors are multifunctional
Sporn, M. B., & Roberts, A. B. (1988) · Nature · doi:10.1038/332217a0 · Cited by 818
Robb, R. J., Greene, W. C., & Rusk, C. M. (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.4.1126 · Cited by 725
Self-citationHatakeyama, M., Tsudo, M., Minamoto, S., Kono, T., Doi, T., Miyata, T., Miyasaka, M., & Taniguchi, T. (1989) · Science · doi:10.1126/science.2785715 · Cited by 677
The IL-2 Receptor Complex: Its Structure, Function, and Target Genes
Minami, Y., Kono, T., Miyazaki, T., & Taniguchi, T. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.001333 · Cited by 604
Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2
Johnston, J. A., Kawamura, M., Kirken, R. A., Chen, Y.-Q., Blake, T. B., Shibuya, K., Ortaldo, J. R., McVicar, D. W., & O'Shea, J. J. (1994) · Nature · doi:10.1038/370151a0 · Cited by 595
Hatakeyama, M., Kono, T., Kobayashi, N., Kawahara, A., Levin, S. D., Perlmutter, R. M., & Taniguchi, T. (1991) · Science · doi:10.1126/science.2047859 · Cited by 561
Lineage promiscuity in hemopoietic differentiation and leukemia
Greaves, M., Chan, L., Furley, A., Watt, S., & Molgaard, H. (1986) · Blood · doi:10.1182/blood.v67.1.1.1 · Cited by 551
Biology of the Interleukin-2 Receptor
Nelson, B. H., & Willerford, D. M. (1998) · Advances in Immunology · doi:10.1016/s0065-2776(08)60386-7 · Cited by 475
Waldmann, T. A. (1986) · Science · doi:10.1126/science.3008337 · Cited by 453
Self-citationHatakeyama, M., Mori, H., Doi, T., & Taniguchi, T. (1989) · Cell · doi:10.1016/0092-8674(89)90607-7 · Cited by 360
Waldmann, T. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)49895-x · Cited by 345
Self-citationKipps, T. J. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60663-x · Cited by 321
Taga, T., Kawanishi, Y., Hardy, R. R., Hirano, T., & Kishimoto, T. (1987) · The Journal of experimental medicine · doi:10.1084/jem.166.4.967 · Cited by 310
Wakasugi, N., Tagaya, Y., Wakasugi, H., Mitsui, A., Maeda, M., Yodoi, J., & Tursz, T. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.21.8282 · Cited by 282
Interleukin-2 and interleukin-15: immunotherapy for cancer
Fehniger, T. A., Cooper, M. A., & Caligiuri, M. A. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(01)00021-1 · Cited by 280
Epidermal growth factor regulates the expression of its own receptor.
Clark, A. J., Ishii, S., Richert, N., Merlino, G. T., & Pastan, I. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.24.8374 · Cited by 258
The effects of conjugated linoleic acid supplementation on immune function in healthy volunteers
Nugent, A. P., Roche, H. M., Noone, E. J., Long, A., Kelleher, D. K., & Gibney, M. J. (2005) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602132 · Cited by 71
Bacha, P., Forte, S. E., Perper, S. J., Trentham, D. E., & Nichols, J. C. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220702 · Cited by 27
Metadata
- Authors
- Waldmann, T. A., Goldman, C. K., Robb, R. J., Depper, J. M., Leonard, W. J., Sharrow, S. O., Bongiovanni, K. F., Korsmeyer, S. J., & Greene, W. C.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1984-11-01
- Volume
- 160
- Issue
- 5
- Pages
- 1450-1466
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2145498103
- Cited by
- 482
- References
- 19
- FWCI
- 21.29
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.